England has documented 2,468 laboratory-confirmed measles cases between 2023 and 2026, representing a dramatic resurgence that undermines decades of public health progress. The outbreak demonstrates continuous endemic transmission across multiple regions, surpassing the World Health Organization’s elimination threshold of 12 months without transmission. Urban centers with historically lower vaccination coverage have emerged as primary transmission hubs, reflecting broader patterns of vaccine hesitancy affecting communities across Europe. Public health modeling from the UK Health Security Agency indicates that communities falling below the critical 95% vaccination coverage threshold create vulnerable populations capable of sustaining disease transmission chains. The measles-mumps-rubella vaccine demonstrates 97% efficacy after two doses, yet coverage gaps in specific demographics continue to facilitate ongoing transmission. Healthcare providers emphasize that this outbreak represents a critical juncture for vaccination advocacy and community engagement efforts.
Read the full article on GMJ Newsroom.
Was this article helpful?
